# Cullinan Oncology

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/cullinan-oncology

- Industry: Pharmaceuticals
- Headquarters: Cambridge, US
- Website: www.cullinanoncology.com/
- Total disclosed funding: $380M
- Latest round: Series C (Dec 17, 2020)
- Investors on record: 15

## About

Based in Massachusetts, US, and founded in 2017 by co-founders Patrick Baeuerle, Ph.D., and Karl Wittrup, Ph.D., Cullinan Oncology, LLC operates as a developer of therapeutics for the treatment of cancer. Park Vale Capital, Baupost Group, Eventide Asset Management, and Logos Capital fully exited their stake in Cullinan Oncology, LLC, for an undisclosed amount. As of 2024, the company is led by its CEO, Nadim Ahmed. The firm trades on NASDAQ under the Ricker symbol CGEM.

The company provides a wide range of therapeutic products, such as monoclonal antibodies, small molecules, and bispecific antibodies for oncology and autoimmune indications.

## Funding rounds

- Series C, Dec 17, 2020, $131M — OrbiMed Advisors, Baupost Group, Schooner Capital, Nextech, MPM BioImpact, F2 Ventures, Foresite Capital, BVF Partners, Rock Springs Capital, Eventide Asset Management, Boxer Capital, Logos Capital, Cowen Healthcare Investments, Venrock Healthcare Capital Partners
- Series B, Jun 3, 2020, $99M — MPM BioImpact, F2 Ventures
- Series A, Oct 3, 2017, $150M — MPM BioImpact, F2 Ventures, Park Vale Capital

## Investors

- MPM BioImpact (https://capitalatlas.ai/funds/mpm-bioimpact) — Series A, Series B, Series C
- F2 Ventures (https://capitalatlas.ai/funds/f2-ventures) — Series A, Series B, Series C
- Park Vale Capital (https://capitalatlas.ai/funds/park-vale-capital) — Series A
- OrbiMed Advisors (https://capitalatlas.ai/funds/orbimed-advisors) — Series C
- Baupost Group — Series C
- Schooner Capital (https://capitalatlas.ai/funds/schooner-capital) — Series C
- Nextech (https://capitalatlas.ai/funds/nextech) — Series C
- Foresite Capital (https://capitalatlas.ai/funds/foresite-capital) — Series C
- BVF Partners (https://capitalatlas.ai/funds/bvf-partners) — Series C
- Rock Springs Capital — Series C
- Eventide Asset Management (https://capitalatlas.ai/funds/eventide-asset-management) — Series C
- Boxer Capital (https://capitalatlas.ai/funds/boxer-capital) — Series C
- Logos Capital (https://capitalatlas.ai/funds/logos-capital) — Series C
- Cowen Healthcare Investments — Series C
- Venrock Healthcare Capital Partners (https://capitalatlas.ai/funds/venrock-healthcare-capital-partners) — Series C